Form 4 for ONC BeOne Medicines Ltd.
Accepted 2025-05-13 00:00:00 ET · period of report 2025-05-09 · accession 0001651308-25-000079 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-13 | 2025-05-09 | ONC | OYLER JOHN | CEO, Dir | F - Tax | $17.85 | -1.99M | 8.16M | -20% | -$35.53M |
| D | 2025-05-13 | 2025-05-09 | ONC | OYLER JOHN | CEO, Dir | M - OptEx | $0.5 | +4.06M | 10.15M | +66% | +$2.03M |
| D | 2025-05-13 | 2025-05-09 | ONC | OYLER JOHN | CEO, Dir | M - OptEx | $0.00 | -4.06M | 7 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-05-09 | F | D | 1,990,603 | $17.85 | 8,163,437 | D | — | — | |
| 2 | Common | Ordinary Shares | 2025-05-09 | M | A | 4,055,415 | $0.5 | 10,154,040 | D | — | — | |
| 3 | Derivative | Share Option (Right to Buy) | 2025-05-09 | M | D | 4,055,415 | $0.00 | 7 | D | $0.5 · — to 2025-07-19 | 4,055,415 Ordinary Shares | (F7) These securities vest over a five-year period as follows: 20% on July 19, 2016, and the remaining in 48 successive equal monthly installments, subject to continued service. |